评论
打印
UPI reports Food and Drug Administration has approved a prescription-only nasal spray to treat depression
UPI报道称食品药品监督管理局（FDA）批准了鼻腔喷雾剂可用于治疗抑郁症
marking the first medical advancement in fighting the affliction in more than 30 years.
标志着30多年来在抗击抑郁症上取得的首次医学进步。
The agency approved Johnson & Johnson's Spravato, which will carry the FDA's strongest box warning due to abuse potential.
管理局批准了美国强生的Spravato，由于其滥用潜力，Spravato将被贴有FDA最强的方框警告。
FDA Dr. Tiffany Farchione said in a statement
FDA的Tiffany Farchione博士在声明中表示
"There has been a long-standing need for additional effective treatments for treatment-resistant depression, a serious and life-threatening condition."
“长期以来我们都需要附加有效的方法来治疗耐药性抑郁症，这是一种严重且会危及生命的疾病。”
译文属可可英语原创，未经允许，不得转载。
